Induced Sputum Study (0000-065)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015)
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Effects of ER Niacin/Laropiprant, Laropiprant, ER Niacin, and Placebo on Urinary Prostanoid Metabolites (0524A-079)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Study on Raltegravir and Lamotrigine
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)
- Status
- TERMINATED
- Phase
- PHASE2
Antihypertensive Response to Losartan and Genetic Polymorphisms
- Status
- COMPLETED
- Phase
- NA
Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)
- Status
- COMPLETED
- Phase
- PHASE3
MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection
- Status
- TERMINATED
- Phase
- PHASE2
Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)
- Status
- COMPLETED
- Phase
- PHASE2
Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708)
- Status
- COMPLETED
- Phase
- PHASE3
Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)
- Status
- COMPLETED
- Phase
- PHASE2
Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)
- Status
- COMPLETED
- Phase
- PHASE2
Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Add-on Simvastatin in Schizophrenia Trial
- Status
- TERMINATED
- Phase
- NA
Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)
- Status
- TERMINATED
- Phase
- PHASE4
A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE4